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Abstract 
Background: Prosthetic Mitral valve dysfunction is a serious complication associated 
with a high mortality rate particularly in obstructive cases. The number of cases 
undergoing redo mitral valve surgery is increasing. This study aims to identify the risk 
factors of mortality and morbidity in patients who underwent redo mitral valve surgery 
for prosthetic mitral valve dysfunction.
Methods: This study was conducted on 80 patients who underwent re-operation for 
management of prosthetic mitral valve dysfunction from December 2014 to February 
2018. Patients’ age ranged between 21 and 58 years with a mean of 36.8±9.60 years, 
and 53 patients (66.3%) were males. The causes of mitral valve malfunction were 
thrombus in 67 patients (83.7%) and pannus in 13 patients (16.3%). 
Results: 53 patients (66.25%) had urgent surgical intervention. Thrombectomy or 
pannus resection was done in 75 patients (93.75%) and valve replacement in 5 patients 
(6.25%). Re-exploration was required in 11 patients (13.75%) and was significantly 
associated with diabetes (p= 0.004), preoperative liver dysfunction (p= 0.04), elevated 
INR (p= 0.006), trial of thrombolysis (p<0.001) and prolonged ischemic time (p= 0.01). 
Postoperative renal failure occurred in 11 patients (13.75%) and was associated with 
diabetes (p< 0.001), preoperative renal dysfunction (p< 0.001), prolonged 
cardiopulmonary bypass and ischemic times (p< 0.001). 17 patients (21%) required 
prolonged mechanical ventilation and it was significantly associated with chronic 
obstructive lung disease (p< 0.001), pulmonary edema (p <0.001), low systolic blood 
pressure (p <0.001), low ejection fraction (p<0.001) and thrombectomy (p<0.001). 
Operative mortality occurred in 13 patients (16%) and was significantly associated with 
preoperative stroke, renal dysfunction, low blood pressure and acute pulmonary edema 
(p <0.001). 
Conclusion: Reoperation for prosthetic mitral valve dysfunction is associated with high 
morbidity and mortality. Outcomes can be predicted based on preoperative clinical 
status and operative times. Thrombectomy and pannus resection with the repair of the 
paravalvular leak is a simple and easy technique for management of those patients with 
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Despite the advancement achieved in valve 
surgery, prosthetic mitral valve dysfunction is a 
serious complication associated with high 
mortality, particularly in obstructive cases. Several 
studies were carried out to identify the risk 
factors for prosthetic valve dysfunction [1], and 
an algorithm for management of obstructive 
thrombosed prosthetic heart valve was 
developed recently [2]. With the advances in 
cardiac surgery, the longevity of patients has 
improved, and consequently more patients are 
referred for redo surgery for several reasons. 
Reoperations carry high risk due to advanced 
patients age and comorbidities, in addition to the 
technical challenges [3]. 
Prosthetic valves dysfunction may be caused 
by suture line dehiscence leading to paravalvular 
regurgitation or breakage and separation of the 
valve components or valve obstruction. Several 
factors; such as thrombosis, pannus formation, 
bacterial endocarditis, chordal debris, and 
papillary muscle entrapment can cause 
mechanical malfunctions of prosthetic heart 
valves. Thrombosis or pannus formation is 
considered as the most common causes of 
prosthetic mitral valve obstruction [4].  
Compared to the bioprosthetic valves, 
mechanical valves are more durable but carry the 
risk of thrombosis and obstruction [5] which occur 
in 1- 2.7% per patient-year in the aortic position 
and 1- 4.4% per patient-year in the mitral position 
[6, 7]. Surgery is the primary treatment modality 
for the management of thrombosed mechanical 
valves; however, thrombolytic therapy became an 
alternative and is increasingly used as the first line 
therapy for mechanical valve obstruction [8]. 
We aimed in this study to investigate the risk 
factors of mortality and morbidity in patients who 
underwent redo mitral valve surgery for 
prosthetic mitral valve dysfunction.  
Patients and Methods: 
This prospective cohort study was conducted 
on 80 patients who underwent re-operation for 
management of prosthetic mitral valve 
thrombosis or malfunction from December 2014 
to February 2018. Prosthetic valve dysfunction 
was defined as any change in the valve function 
causing significant stenosis or regurgitation [4]. 
In this study, we included all patients presented 
with mechanical or bioprosthetic mitral valve 
dysfunction and had isolated mitral valve surgery 
with or without tricuspid repair. We excluded 
patients with infective prosthetic endocarditis and 
those who had concomitant cardiac surgical 
procedure or had a previous coronary artery 
bypass grafting. 
The Ethical Committee approved the study, and 
patients’ consent was obtained before 
enrollment.  
Preoperative preparation: 
All patients were evaluated by detailed 
preoperative history taking and physical 
examination. Details of the prior surgery were 
reported including the access, valve type, and size 
and the last dose of the anticoagulant. Chest X-
rays (posteroanterior and lateral views) were 
performed to assess the chest condition, the 
number of stainless-steel wires of previous 
sternotomy and the relation between the heart 
and the sternum. Echocardiography (transthoracic 
TTE with or without transesophageal TEE) was 
done to assess leaflet mobility, presence of 
thrombi, vegetation, paravalvular leak, valve 
dehiscence, pulmonary artery pressure, chamber 
dimensions, and ejection fraction. Fluoroscopy 
was done if the echocardiography was not 
conclusive for valve mobility. Blood culture was 
performed in suspected cases of endocarditis. 
Once the diagnosis of prosthetic dysfunction 
was confirmed, all patients were admitted to the 
intensive care unit. Surgical interventions were 
performed without correction of INR especially in 
patients with poor clinical status or pulmonary 
edema. 
Operative Technique: 
All operations were carried out under general 
anesthesia and through median sternotomy using 
the oscillating saw. After the sternum was re-
opened, major bleeding points from the edges 
were controlled. An appropriate sternal retractor 
was then placed and opened slowly. Access to the 
aorta and right atrium was done first. Purse strings 
were placed so that cannulation can be performed 
quickly if bleeding occurs. Femoral vessels were 
exposed in selected cases (e.g., suspicion of severe 
mediastinal adhesions or high central venous
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Figure 1: (A) Prosthetic valve with thrombus and pannus after removal from the patients. (B) Organized and fresh 
thrombus after thrombectomy
pressure after induction of anesthesia). The 
femoral artery was exposed and prepared without 
cannulation in 14 cases before opening the 
sternum, and it was cannulated in 3 cases. 
The left pleural space was opened to drop the 
left ventricular apex to improve mitral valve 
exposure. The aorta is cannulated distal to the 
former site of cannulation to avoid unyielding 
fibrous tissue. If the adhesions on the aorta make 
dissection difficult, the pericardial reflection was 
opened, and the aorta was cannulated close to the 
brachiocephalic trunk. When the aorta was cross-
clamped, antegrade cold blood cardioplegia was 
given and systemic hypothermia to 28-32°C was 
used. Repeated doses of cardioplegia were given 
every 30 minutes.  
After complete cardiac arrest, the left atrium 
was opened. Simple thrombectomy was 
appropriate in most patients with or without 
pannus resection or repair of the paravalvular 
leak. Replacement of the valve was preferred if 
the thrombus is inaccessible on the ventricular 
surface of the valve or thrombotic material 
undistinguished from the vegetation of 
endocarditis (Figure 1). 
Post-operative Care: 
All Patients were transferred to the ICU on 
inotropic support if needed. They were monitored 
continuously for arterial pressure through an 
invasive arterial cannula, central venous pressure 
through a venous line inserted in the internal 
jugular vein and the urine output. Weaning from 
inotropic support and mechanical ventilation was 
started when the patient was hemodynamically 
stable. Patients were left in the ICU for 12-24 
hours after weaning from mechanical ventilation 
and inotropic support; then they were transferred 
to the ward after removal of central venous line 
and drainage tubes. Patients were discharged 
from the hospital with a clean wound, stable 
sternum, normal laboratory findings with INR 
within the therapeutic level and absence of fever. 
Definitions: 
Hepatic dysfunction was defined as serum 
bilirubin >2.0 mg/dL. Urgent operations were 
defined as a surgical intervention within 24 hours 
of the hospital admission. Postoperative renal 
failure is the requirement for new dialysis 
postoperatively. Prolonged mechanical ventilation 
is the need for ventilatory support for more than 
24 hours and prolonged ICU stay as the stay in ICU 
for more than 72 hours. Sternal wound infections 
were defined as infections that required operative 
intervention. Re-exploration for bleeding was 
defined as the drainage of more than 500ml in the 
1st hour, 800ml in the first 2 hours, 900ml in the 
first 3 hours, 1000ml in the first 4 hours, 1200ml in 
the first 5 hours or sudden massive bleeding with 
hemodynamic instability or cardiac tamponade. 
Paravalvular leak refers to the regurgitation of 
blood due to causes other than infective 
endocarditis. Prosthetic valve failure refers to all 
other causes of prosthetic valve dysfunction 
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Table 1: Baseline characteristics of the patients. Continuous variables are presented as mean± SD and categorical 








Diabetes mellitus  (n) 
History of cerebrovascualr accident (n) 
Preoperative renal dysfunction (n) 





Symptoms and signs 
New York Heart Association (NYHA) class III(n) 
NYHA class IV(n) 
Acute pulmonary edema(n) 
Lower limb edema (n) 
Chronic obstructive pulmonary disease 







Mean arterial blood pressure <70 mmHg (n) 
Heart rate > 100 (n) 
25(31.3%) 
46(57.5%) 
Creatinine (mg/dL) (mean ±SD) 
INR (International normalization ratio)<2(n) 
INR mean±SD 





Time to operation 
Emergency (within few hours) (n) 
Urgent ≤ 24 hours (n) 




Transthoracic echocardiographic data 
Ejection fraction (EF) (%) mean±SD 
EF<50%(n) 
EF>50%(n) 
Systolic pulmonary artery pressure (SPAP) (mmHg) mean±SD 
SPAP <60 mmHg (n) 
SPAP >60 mmHg (n) 








Echocardiography of the mitral valve prosthesis 









including valve thrombosis, tissue ingrowth, and 
mechanical dysfunction. 
Statistical analysis 
Data were summarized as proportions, 
percentages for categorical variables and 
continuous data were presented as mean ± SD. 
Categorical variables were compared using the 
Pearson's Chi-squared test or Fisher's exact test, 
and independent continuous variables were 
compared by the unpaired Student t-test or 
Kruskal-Wallis test as appropriate. The analysis 
was performed by the Statistical Package for the 
Social Sciences (SPSS Version 23, IBM Corporation, 
Chicago, IL, USA). P-value <0.05 was considered 
statistically significant. 
Results 
The age of our patients ranged between 21- 58 
years with a mean of 36.8±9.60 years and 53 of 
them (66.3%) were males. Baseline 
characteristics of the studied patients are shown 
in Table 1. The diagnosis was done by clinical data 
and transthoracic echocardiography (TTE), and in 
ten patients, transesophageal echocardiography 
(TEE) was needed to confirm the diagnosis. 
The cause of mitral valve malfunction was 
thrombus in 67 patients (83.7%), pannus in 13 
patients (16.3%), and paravalvular leak in 7 
patients (8.75%). Thrombectomy and pannus 
resection were done in 75 patients (93.75%) and 
valve re-replacement in 5 patients (6.25%). Direct 
left atriotomy was used in 36 patients (45%), and 
the transseptal approach in 44 patients (55%). 
Seven patients needed femoral cannulation 
(8.8%). Cardiopulmonary bypass (CPB) time 
exceeded 120 minutes in 24 patients (30%). 
Eleven patients (13.8%) needed re-exploration 
for postoperative bleeding, and 17 patients 
(21.2%) had prolonged ventilation. Postoperative 
renal dysfunction occurred in 11 patients (13.8%), 
and chest infection in 14 (17.5%) patients. The 
mean of ICU stay was 99.16± 68.90 hours, and 
48(60%) patients had ICU stay for more than 72 
hours. The mean hospital stay was 10.78± 2.36 
days. Operative mortality occurred in 13 patients 
(16.2%) (Table 2). 
Re-exploration for bleeding was significantly 
associated with preoperative liver dysfunction,  
Table 2: Postoperative complications. Continuous 
variables are presented as mean± SD and categorical 
variables as number and percentage. 
Postoperative complications n=80 

















ICU stay (hours) Mean± SD 
ICU stay ≤72 hours 
ICU stay >72 hours 





Operative mortality 13(16.3%) 
preoperative INR >2 and trial of thrombolysis. 
(Table 3) Postoperative renal failure was 
significantly correlated with preoperative renal 
dysfunction, diabetes mellitus, prolonged CPB 
and cross-clamp times. (Table 4) Prolonged 
postoperative mechanical ventilation and ICU stay 
were significantly associated with chronic 
obstructive pulmonary disease (COPD), New York 
Heart Association (NYHA) class IV, acute 
pulmonary edema, mean arterial blood pressure < 
70, ejection fraction (EF) <50 %, chest infection, 
CPB time>120 minutes,  aortic-cross clamp 
time>90 minutes, renal dysfunction and re-
exploration (Table 5 and Table 6). 
Operative mortality was significantly correlated 
with DM, history of cerebrovascular accident, 
renal and liver dysfunction, NYHA class IV, acute 
pulmonary edema, lower limb edema, COPD, 
atrial fibrillation, mean arterial blood pressure < 
70, EF <50%, systolic pulmonary artery pressure 
(SPAP) >60mmHg, CPB time˃120 minutes and 
aortic-cross clamp time˃90 (Table 7).  
Discussion 
Prosthetic valve dysfunction is a life-
threatening complication with an incidence of 
0.1–6.0% per patient-year [9]. The optimal
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Table 3: Risk factors for re-exploration. Continuous variables are presented as mean± SD and categorical variables as 




No (n =69) Yes (n=11) 
Age (Years) 37.23±9.39 34.53±10.70 0.41 
Diabetes mellitus    
History of cerebrovascular accident 
Preoperative renal dysfunction  













International normalization ratio (INR)>2 45(65.2%) 11(100%) 0.006* 
Trial of thrombolysis  







Cardiopulmonary bypass time>120 min. 














management is controversial. Reoperations are 
associated with higher mortality compared to the 
primary operation and are technically demanding 
because of the adhesions around the heart. 
Reoperations are generally performed in a 
functionally compromised group of patients; 
therefore, these patients tolerate complications 
poorly [10]. 
The outcomes in our study were affected by 
the preoperative clinical status and the 
cardiopulmonary bypass and ischemic times. Re-
exploration was required in 13.7% of our patients, 
and because of the urgency of the operation, most 
of the patients underwent surgery with elevated 
INR. High preoperative INR and trials of 
thrombolysis increased the risk of postoperative 
bleeding. Total bypass time and hepatic 
dysfunction were risk factors for postoperative 
bleeding. Valve dysfunction may lead to hepatic 
congestion preoperatively which affects the 
coagulation factors. Moreover, the CPB has a 
negative effect on the coagulation mechanisms 
which was exaggerated by prolonged total bypass 
time. Pansini and associates had excessive 
postoperative bleeding (defined as bleeding of 
more than 1000 ml in the first 24 hours 
postoperatively) in 14.5% of the patients while 
re-exploration was required in 8% of them [11].
Table 4: Risk factors for postoperative renal failure. Continuous variables are presented as mean± SD and categorical 




No (n =69) Yes (n=11) 
Age (Years) 36.62±9.85 37.90±8.11 0.68 
Diabetes mellitus    
Preoperative renal dysfunction  










Mean blood pressure˂70 mmHg 21(35.0%) 3(27.2%) 0.37 
Cardiopulmonary bypass time>120 min. 








Table 5: Risk factors for prolonged mechanical ventilation. Continuous variables are presented as mean± SD and 
categorical variables as number and percentage. * indicate significant difference between groups (p<0.05). 
Parameters 
Prolonged mechanical ventilation 
P-value 
No (n =63) Yes (n =17) 
Age (Years) 36.42±9.63 38.17±9.64 0.50 
Chronic obstructive pulmonary disease 
Diabetes mellitus    
History of cerebrovascular accident 
Preoperative renal dysfunction  
















Symptoms and signs 
New York Heart Association (NYHA) class III 
NYHA class IV 
Acute pulmonary edema 
Lower limb edema 
















Mean arterial blood pressure < 70 mmHg 







International normalization ratio (INR)<2 49(77.8%) 7(41.4%) <0.001* 
Echocardiographic data 
Ejection fraction (EF)<50 % 







Urgent operation (≤ 24 hours) 47(74.6%) 15(58.8%) 0.23 
Thrombectomy 63(100.0%) 12(70.5%) 
0.001* 
Valve replacement 0(0.0%) 5(29.5%) 


















Cardiopulmonary bypass time>120 min. 







Preoperative renal dysfunction, diabetes 
mellitus, and prolonged CPB and cross-clamp 
times were risk factors for renal failure 
necessitating dialysis which occurred in 13.7% of 
the patients. Akay and colleagues reported 
postoperative renal dysfunction in 14% of their 
patients [12]. Chang and colleagues found that 
diabetes mellitus was associated with acute 
kidney injury [13]. DM has an effect of the renal 
micro-circulation and prolonged CPB time induces 
systemic inflammatory changes which may have 
an independent toxic impact on the kidneys. 
NYHA class, renal impairment, and prolonged 
CPB and cross-clamp times were risk factors for 
prolonged ICU stay and mechanical ventilation. 
Pulmonary complications occurred in 9 patients
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Table 6: Risk factors for prolonged ICU stay. Continuous variables are presented as mean± SD and categorical variables 
as number and percentage. * indicate significant difference between groups (p<0.05). 
Parameters 
Prolonged ICU stay 
P-value 
No (n=48) Yes (n=32) 
Age (Years) 37.12±9.72 36.31±9.54 0.71 
Chronic obstructive pulmonary disease 
Diabetes mellitus    
History of cerebrovascular accident 
Preoperative renal dysfunction  
















Symptoms and signs 
New York Heart Association (NYHA) class III 
NYHA class IV 
Acute pulmonary edema 
Lower limb edema 

















Ejection fraction (EF)<50% 














Urgent operation (≤ 24 hours) 34(70.8%) 28(87.5%) 0.08 
Postoperative parameters 

























Cardiopulmonary bypass time>120 min. 







(11.25%). Risk factors for prolonged ventilation 
and ICU stay differ between studies because of the 
variations in comorbidities and different baseline 
patients’ characteristics [14, 15]  
Operative mortality was significantly 
associated with the history of stroke, renal failure, 
acute pulmonary edema, NYHA class IV, prolonged 
CPB and cross-clamp times, mean arterial blood 
pressure <70 mmHg, and ejection fraction˂50%. 
Mortality occurred in 13 patients (16.3%), and the 
reported operative mortality ranged from 10% to 
40% in emergency operations [11, 12]. In our 
study, the sex and age did not affect hospital 
mortality; however, advanced age is associated 
with a decreased physiologic reserve and 
increased morbidity. In accordance with these 
findings, several series showed that age and 
gender did not affect the hospital mortality [15, 
16], and in other series, female gender was a risk 
factor for mortality [12, 17].
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Table 7: Risk factors for operative mortality. Continuous variables are presented as mean± SD and categorical variables 




No (n=67) Yes (n=13) 
Age  
Female  










Diabetes mellitus    
History of cerebrovascular accident 
Preoperative renal dysfunction  













Symptoms and signs 
New York Heart Association (NYHA) class III 
NYHA class IV 
Acute pulmonary edema 
Lower limb edema 
Chronic obstructive pulmonary disease 



















Mean arterial blood pressure < 70 mmHg 







International normalization ratio (INR)<2 49(73.1%) 7(53.8%) 0.07 
Echocardiographic data 
Ejection fraction (EF)<50% 
Systolic pulmonary artery pressure (SPAP) >60 mmHg 






















Time from last operation (months) mean± SD 








































Cardiopulmonary bypass time˃ 120 min 
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Diabetes was not a risk factor for hospital 
mortality which could be attributed to the small 
number of diabetic patients in our study.  
Preoperative renal impairment negatively 
affected operative mortality [18, 19]. Patients 
presented with valve obstruction and low blood 
pressure are prone to kidney injury which further 
leads to fluid retention and exaggerates the heart 
failure. In agreement with other studies, the 
previous stroke was associated with higher 
mortality [20]. Stroke can occur due to 
concomitant carotid disease or embolization from 
left atrial thrombus. Recent hemorrhagic or 
ischemic stroke is a contraindication to elective 
cardiac surgery as it is associated with high 
mortality.   
The pathology of the mitral valve dysfunction 
had no impact on mortality. Other studies found 
that the indication for surgery had no effect on 
hospital mortality [14, 16]; meanwhile, other 
series found that operative mortality was 
significantly higher in reoperation for prosthetic 
endocarditis [21, 22]. In our study, we excluded 
patients with infective endocarditis, and the 
outcomes were not affected by the pathology of 
valve dysfunction. This could be attributed to the 
variable severity of the same valve pathology; 
therefore, a variable effect on the clinical status of 
the patients. Emergency surgery was associated 
with operative mortality which reflected the bad 
clinical condition of the patients that required 
immediate intervention without routine 
preparation [17, 18]. The reported mortality risk 
of elective reoperation was 5.4%- 11%, while, for 
emergency procedures, it could be as high as 38% 
to 61.5% [19]. 
The cardinal cause of prosthetic valve 
thrombosis in our series was inadequate 
coagulation. Thrombectomy and pannus resection 
with the repair of a paravalvular leak were our 
preferred surgical techniques. The technique is 
simple and has a low CPB and ischemic times 
compared to valve replacement. Mortality in the 
current study was significantly associated with 
long CPB and cross-clamp times which is 
consistent with the published series [16, 19, 23]. 
The cause of the prolonged CPB time was the 
lengthy weaning from the circulatory support 
because of the associated poor left ventricular 
function [20] which is a risk factor for morality [24, 
25]. 
Study limitations: 
The main limitation of the study is the 
relatively small sample size. Univariable risk 
factors for morbidity and mortality after 
reoperation for mitral valve dysfunction were 
identified; however, there could be interaction 
and confounding factors that were not be 
adjusted because of the small number of events. 
The other limitation is the single center 
experience, and the results cannot be generalized 
to other patients. However, the study presents the 
outcomes of a relatively uncommon condition and 
evaluates the effect of thrombectomy as an 
approach for those patients which is not 
thoroughly evaluated in the literature. 
Conclusion 
Reoperation for prosthetic mitral valve 
dysfunction is associated with high morbidity and 
mortality. Outcomes can be predicted based on 
preoperative clinical status and operative times. 
Thrombectomy and pannus resection with the 
repair of the paravalvular leak is a simple and easy 
technique for management of those patients with 
a reduction of cardiopulmonary bypass and cross-
clamp times. 
Conflict of interest: Authors declare no conflict of 
interest. 
References 
1. Deviri E, Sareli P, Wisenbaugh T, and cronge
S.L. Obstruction of mechanical heart valve
prostheses: clinical aspects and surgical
management. J Am Coll Cardiol, 1991; 17: 646-
50.
2. Huang G, Schaff HV, and Sundt TM. Treatment
of obstructive thrombosed prosthetic heart
valve. J Am Coll Cardiol, 2013; 62: 1731-6.
3. Khan NU and Yunnan N. Does preoperative
computed tomography reduce the risks
associated with re-do cardiac surgery?
Interact. Cardiovasc. Thorac Surg, 2009: 9 (1);
119–23.
4. Rallidis LS, Papadopoulos C, Kanakakis J,
Paraskevaidis I, and Kremastinos DI. Obstruction
68 
alternans’ of a Sorin tilting disc prosthetic mitral 
valve: a case of emergency action. Eur. J. 
Echocardiogr 2008: 9(5); 704–6. 
5. Bonow RO, Carabello BA, Chatterjee K, et al.
ACC/AHA 2006 guidelines for the management
of patients with valvular heart disease. : a report
of the American College of Cardiology/American
Heart Association Task Force on Practice
Guidelines (writing Committee to Revise the
1998 guidelines for the management of patients
with valvular heart disease) developed in
collaboration with the Society of Cardiovascular
Anesthesiologists endorsed by the Society for
Cardiovascular Angiography and Interventions
and the Society of Thoracic Surgeons. J Am
CollCardiol 2006; 48: e1-148.
6. Akins CW. Results with mechanical cardiac
valvular prostheses. Ann Thorac.Surg 1995; 60:
1836-44.
7. Vitale N, Renzulli A, Agozzino L, et al. Obstruction
of mechanical mitral prostheses: analysis of
pathologic findings. Ann ThoracSurg 1997; 63:
1101-6.
8. Roudaut R, Lafitte S, Roudaut MF, et al.
Fibrinolysis of mechanical   prosthetic valve
thrombosis: a single-center study of 127 cases. J
Am CollCardiol 2003; 41: 653-8.
9. Habets J, Budde RP, Symersky P, et al. Diagnostic
evaluation of left-sided prosthetic heart valve
dysfunction. Nat Rev Cardiol 2011;8:466-78.
10. Sampath Kumar A, Dhareshwar J, Airan B, Bhan
A, Sharma R and Venugopal P. Redo mitral valve
surgery-a long-term experience. J. Card. Surg.
2002: 19(4); 303–7.
11. Pansini S, Ottino G, Forsennati PG, et al.
Reoperations on heart valve prostheses: An
analysis of operative risks and late results. Ann.
Thorac. Surg 1990: 50(4); 590–596
12. Akay TH, Gultekin B, Ozkan S, et al. Mitral valve
replacements in redo patients with previous
mitral valve procedures: mid- term results and
risk factors for survival. J. Card. Surg 2008: 23(5);
415–21.
13. Chang CH, Lee CC, Chen SW, et al. Predicting
acute kidney injury following mitral valve repair.
Int J Med Sci 2016; 13(1): 19-24.
14. Potter DD, Sundt TM, Zehr KMJ, et al. Risk of
repeat mitral valve replacement for failed mitral
valve prostheses. Ann. Thorac. Surg 2004: 78 (1):
67–72.
15. Piehler JM, Blackstone EH, Bailey KR, et al.
Reoperation on prosthetic heart values. Patient- 
specific estimates of in-hospital events. J.
Thorac. Cardiovasc. Surg 1995: 109(1); 30–48.
16. Jones JM, O’kane H, Gladstone DJ, et al. Repeat
heart valve surgery: risk factors for operative
mortality. J. Thorac. Cardiovasc. Surg
2001:122(5): 913–8.
17. Beghi C, De Cicco G, Nicolini F, Ballore L,
Reverberi C, and Gherli T. Cardiac valve
reoperations: analysis of operative risk factors in
154 patients. J. Heart Valve Dis 2002: 11 (2);
258–62.
18. Matsuyama K, Matsumoto M, Sugita T,
Nishizawa J, Kawansihi Y, and Uehara K. Long-
term results of reoperative mitral valve surgery
in patients with rheumatic disease. Ann. Thorac.
Surg 2003: 76 (6); 1939–1943.
19. Vohra HA, Whistance RN, Roubelakis A, et al.
Outcome after redo-mitral valve replacement in
adult patients: a 10-year single-centre
experience. Interact Cardiovasc Thorac Surg
2012: 14 (5); 575–9.
20. Maciejewski M, Piestrzeniewicz K, Bielecka-
Dąbrowa A, Piechowiak M, and Jaszewski R.
Redo surgery risk in patients with cardiac
prosthetic valve dysfunction. Arch. Med. Sci
2011: 7 (2); 271–7.
21. Brandão DCM, Pomerantzeff PMA, Souza LR, et
al. Multivariate analysis of risk factors for
hospital mortality in valvular reoperations for
prosthetic valve dysfunction. Eur. J.
Cardiothorac. Surg. 2002: 22 (6); 922–6.
22. Wauthy P, Goldstein JP, Demanet H, and
Deuvaert FE. Redo valve surgery nowadays:
what have we learned?. ActaChir. Belg 2003:103
(5): 475–80.
23. Mazzucco A, Milano A, Mazzaro E, and Bortolotti
U. Reoperation in patients with a bioprosthesis
in the mitral position: indications and early
results. J. Heart Valve Dis 1993: 2 (6); 646–8.
24. McGrath LB, Fernandez J, Laub GW, Anderson
WA, Bailey BM, and Chen C. Perioperative
events in patients with failed mechanical and
bioprosthetic valves. Ann. Thorac. Surg
1995:60(2); S475–8.
25. Dokhan AL, Taher AH, Ibrahim IM, Asfour AM.
The short-term outcome of redo-mitral valve
surgery: emergency versus elective. Menoufia
Med J 2016; 29:668-73.
Badr A. 
